Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid plus cisplatin and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and neck
2014-001523-69Phase 2Active
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in head and neck squamous cell carcinoma (HNSCC), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: Overall response rate. Started Jun 2014; status: active.
02
Drugs
valproic acid
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2014-001523-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001523-69.